Inventor · disambiguated record
Robert G. Korneluk
Also filed as: KORNELUK ROBERT G
30 granted patents·29 pending applications·510 citations·filing 1995–2019
97Inventor score
Files withKORNELUK ROBERT G16UNIV OTTAWA14AEGERA THERAPEUTICS INC13APOPTOGEN INC5CHILDRENS HOSPITAL OF EASTERN ONTARIO RES INSTITUTE INC3
Top patents by PatentIndex Score
59 records- 0193US6300492B1Modulation of IAPs for the diagnosis and antisense treatment of proliferative diseaseAEGERA THERAPEUTICS INC·Filed 2000·Granted Oct 9, 2001·33 cites·8 claims
- 0291US6673917B1Antisense IAP nucleic acids and uses thereofUNIV OTTAWA·Filed 2000·Granted Jan 6, 2004·32 cites·22 claims
- 0389US6133437AModulation of IAPs for the treatment of proliferative diseasesAPOPTOGEN INC·Filed 1997·Granted Oct 17, 2000·68 cites·8 claims
- 0487US6946544B2XAF genes and polypeptides: methods and reagents for modulating apoptosisAEGERA THERAPEUTICS INC·Filed 2002·Granted Sep 20, 2005·8 cites·11 claims
- 0586US6156535AMammalian IAP gene family, primers, probes, and detection methodsUNIV OTTAWA·Filed 1995·Granted Dec 5, 2000·33 cites·15 claims
- 0684US6709866B2Methods for enhancing survival of a neuronAEGERA THERAPEUTICS INC·Filed 2000·Granted Mar 23, 2004·16 cites·19 claims
- 0783US7087584B2Detection and modulation of IAPs and NAIP for the diagnosis and treatment of proliferative diseaseAEGERA THERAPEUTICS INC·Filed 2001·Granted Aug 8, 2006·12 cites·8 claims
- 0883US6107041ADetection and modulation of IAPS for the diagnosis and treatment of proliferative diseaseAPOPTOGEN INC·Filed 1998·Granted Aug 22, 2000·41 cites·27 claims
- 0982US6656704B1Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methodsAEGERA THERAPEUTICS INC·Filed 1996·Granted Dec 2, 2003·24 cites·6 claims
- 1080US7294713B2Antisense IAP oligonucleotides and uses thereofAEGERA THERAPEUTICS INC·Filed 2003·Granted Nov 13, 2007·9 cites·9 claims
- 1180US6495339B1Method of identifying a compound that modulates XAF-mediated apoptosisAEGERA THERAPEUTICS INC·Filed 2000·Granted Dec 17, 2002·3 cites·18 claims
- 1279US5919912AMammalian IAP antibodies and diagnostic kitsUNIV OTTAWA·Filed 1995·Granted Jul 6, 1999·50 cites·26 claims
- 1376US6541457B2Mammalian IAP gene family, primers, probes and detection methodsAEGERA THERAPEUTICS INC·Filed 1998·Granted Apr 1, 2003·16 cites·18 claims
- 1473US6977158B1Mammalian IAP gene family, primers, probes, and detection methodsUNIV OTTAWA·Filed 2000·Granted Dec 20, 2005·2 cites·11 claims
- 1572US6171821B1XIAP IRES and uses thereofAPOPTOGEN INC·Filed 1999·Granted Jan 9, 2001·43 cites·29 claims
- 1671US10441654B2SMC combination therapy for the treatment of cancerCHILDRENS HOSPITAL OF EASTERN ONTARIO RES INSTITUTE INC·Filed 2015·Granted Oct 15, 2019·3 cites·6 claims
- 1769US8021840B2Diagnostic marker for interferon responsiveness in multiple sclerosisDIANOVIX INC·Filed 2007·Granted Sep 20, 2011·4 cites·37 claims
- 1868US6159948ATherapeutic and drug screening methods for the treatment and prevention of neuronal diseaseUNIV OTTAWA·Filed 1997·Granted Dec 12, 2000·26 cites·18 claims
- 1968US6020127ANeuronal apoptosis inhibitor protein, gene sequence and mutations causative of spinal muscular atrophyUNIV OTTAWA·Filed 1995·Granted Feb 1, 2000·32 cites·33 claims
- 2067US6107088AXAF genes and polypeptides: methods and reagents for modulating apoptosisAPOPTOGEN INC·Filed 1998·Granted Aug 22, 2000·19 cites·28 claims
- 2166US7776552B2Mammalian IAP gene family, primers, probes and detection methodsUNIV OTTAWA·Filed 2006·Granted Aug 17, 2010·0 cites·6 claims
- 2265US7858309B2Method for differentiating between multiple sclerosis subtypesDIANOVIX INC·Filed 2007·Granted Dec 28, 2010·2 cites·10 claims
- 2365US6159709AXIAP IRES and uses thereofAPOPTOGEN INC·Filed 1998·Granted Dec 12, 2000·28 cites·9 claims
- 2464US2007031904A1Mammalian IAP gene family, primers, probes and detection methodsKORNELUK ROBERT G·Filed 2006·Application pending·0 cites
- 2564US2007027304A1Mammalian IAP gene family, primers, probes and detection methodsKORNELUK ROBERT G·Filed 2006·Application pending·0 cites
- 2664US2007048772A1Mammalian IAP gene family, primers, probes and detection methodsKORNELUK ROBERT G·Filed 2006·Application pending·0 cites
- 2764US2007026494A1Mammalian IAP gene family, primers, probes and detection methodsKORNELUK ROBERT G·Filed 2006·Application pending·0 cites
- 2864US2007066524A1Mammalian IAP gene family, primers, probes and detection methodsKORNELUK ROBERT G·Filed 2006·Application pending·0 cites
- 2964US2007026470A1Mammalian IAP gene family, primers, probes and detection methodsKORNELUK ROBERT G·Filed 2006·Application pending·0 cites
- 3064US2007031903A1Mammalian IAP gene family, primers, probes and detection methodsKORNELUK ROBERT G·Filed 2006·Application pending·0 cites
- 3163US2007203088A1Detection and modulation of IAPs and NAIP for the diagnosis and treatment of proliferative diseaseKORNELUK ROBERT G·Filed 2006·Application pending·0 cites
- 3263US2007009971A1Mammalian IAP gene family, primers, probes, and detection methodsAEGERA THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 3363US2006205021A1Mammalian IAP gene family, primers, probes and detection methodsAEGERA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 3462US2006134077A1Electronic commerce system including customized catalog having encoded informationVERCHERE BRUCE·Filed 2003·Application pending·0 cites
- 3562US2006127927A1Mammalian IAP gene family, primers, probes, and detection methodsUNIV OTTAWA·Filed 2005·Application pending·0 cites
- 3660US7067281B2Mammalian IAP gene family, primers, probes and detection methodsAEGERA THERAPEUTICS INC·Filed 2003·Granted Jun 27, 2006·0 cites·9 claims
- 3760US2006189563A1Detection and modulation of IAPS and NAIP for the diagnosis and treatment of proliferative diseaseKORNELUK ROBERT G·Filed 2006·Application pending·0 cites
- 3859US2009142334A1DETECTION AND MODULATION OF IAPs AND NAIP FOR THE DIAGNOSIS AND TREATMENT OF PROLIFERATIVE DISEASEAEGERA THERPEUTICS INC·Filed 2008·Application pending·0 cites
- 3958US2007142316A1Antisense IAP oligonucleotides and uses thereofKORNELUK ROBERT G·Filed 2006·Application pending·0 cites
- 4057US2007135371A1Antisense IAP nucleobase oligomers and uses thereofLACASSE ERIC·Filed 2006·Application pending·0 cites
- 4157US2007123481A1Antisense IAP oligonucleotides and uses thereofKORNELUK ROBERT G·Filed 2006·Application pending·0 cites
- 4257US2007202096A1XAF genes and polypeptides: methods and reagents for modulating apoptosisKORNELUK ROBERT G·Filed 2006·Application pending·0 cites
- 4357US2007072217A1XAF genes and polypeptides: methods and reagents for modulating apoptosisKORNELUK ROBERT G·Filed 2006·Application pending·0 cites
- 4455US2006040862A1XAF genes and polypeptides: methods and reagents for modulating apoptosisAEGERA THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 4554US2020384103A1Smc combination therapy for the treatment of cancerCHILDRENS HOSPITAL OF EASTERN ONTARIO RES INSTITUTE INC·Filed 2019·Application pending·0 cites
- 4653US6689562B1Mammalian IAP gene family, primers, probes and detection methodsAEGERA THERAPEUTICS INC·Filed 1998·Granted Feb 10, 2004·4 cites·13 claims
- 4753US2001021699A1Therapeutic and drug screening methods for the treatment and prevention of neuronal diseaseUNIV OTTAWA·Filed 2001·Application pending·0 cites
- 4851US7235372B2Use of neuronal apoptosis inhibitor protein (NAIP)UNIV OTTAWA·Filed 2006·Granted Jun 26, 2007·0 cites·8 claims
- 4951US6429011B1Neuronal apoptosis inhibitor protein gene sequence and mutations causative of spinal muscular atrophyUNIV OTTAWA·Filed 2000·Granted Aug 6, 2002·0 cites·15 claims
- 5050US6797473B2Methods and compounds for modulating male fertilityUNIV OTTAWA·Filed 2001·Granted Sep 28, 2004·0 cites·4 claims
Showing the top 50 of 59 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →